保险类型对机器人辅助肺叶切除术后围术期结局的影响
该回顾性研究分析了433例由同一外科医生实施的机器人辅助肺叶切除术患者,比较不同保险类型(私人保险、公共保险、组合保险)的围术期结局和5年总生存率。
要点
- 公共保险患者术后顺利出院几率低于私人保险(OR 0.43)。
- 公共或组合保险与5年总生存率较差独立相关(HR 2.84/2.68)。
- 保险类型与术中并发症、住院时间或院内死亡率无关。
核心结论
- 公共或组合保险类型与全因死亡风险增加相关,公共保险类型与术后顺利出院几率降低及总体中转开胸相关。
- 保险类型未增加术中并发症、住院时间或院内死亡率。
研究设计与样本
- 回顾性分析433例连续患者,均由同一外科医生在80个月内实施机器人辅助肺叶切除术。
- 排除12例无保险患者(样本量小)。
- 使用Pearson χ2、方差分析、Kruskal-Wallis检验比较变量,Cox回归进行生存分析。
主要发现
- 私人保险107例(平均年龄57.5岁),公共保险118例(平均年龄70.3岁),组合保险196例(平均年龄71.8岁;P < .001)。
- 公共保险组当前吸烟者更多,组合保险组既往吸烟者更多,私人保险组不吸烟者更多(P = .03)。
- 公共和组合保险组比私人保险组有更多合并症,包括胃食管反流病(P = .003)、高血压(P = .01)和高脂血症(P < .001)。
- 肿瘤大小或病理分期无组间差异。
- 私人保险和公共保险组术中中转开胸比例高于组合保险组(P = .001)。
关键数值与推荐
- 公共保险 vs 私人保险:顺利出院 odds ratio 0.43(95%CI 0.22-0.85,P = .02)。
- 组合保险 vs 私人保险:5年OS hazard ratio 2.68(95%CI 1.26-5.67,P = .01)。
- 公共保险 vs 私人保险:5年OS hazard ratio 2.84(95%CI 1.37-5.89,P = .01)。
临床怎么用
- 对于接受机器人辅助肺叶切除术的肺癌患者,应关注保险类型所反映的社会经济差异对术后出院去向和远期生存的潜在影响。
- 公共保险患者可能需要额外的围术期支持和出院规划以改善顺利出院率。
- 保险类型不应作为限制手术选择的依据,但可作为风险分层和资源分配的参考因素。
局限性
- 回顾性研究,存在选择偏倚和未测量混杂因素。
- 单外科医生经验,结果外推性受限。
- 无保险患者样本量小被排除,可能影响结果普遍性。
- 未详细说明保险类型与结局之间因果关系的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Insurance type has been reported to be an independent predictor of overall survival in lung cancer patients. We studied the effect of insurance type on patient outcomes after minimally invasive pulmonary lobectomy for lung cancer. METHODS: We retrospectively analyzed 433 consecutive patients who underwent robotic-assisted pulmonary lobectomy by one surgeon during an 80-month period. Perioperative outcomes and intraoperative and postoperative complications were noted. Disposition at discharge after surgery (favorable, eg, transfer to home with self-care or with home health nursing and/or physical therapy, versus unfavorable, eg, long-term acute care or rehabilitation facility, hospice, or death) and 5-year overall survival (5-years OS) were also recorded. We used Pearson χ2, analysis of variance (ANOVA), and Kruskal-Wallis test to compare variables and Cox regression for survival analysis. RESULTS: There were 107 patients (mean age 57.5 years) with private insurance, 118 (mean age 70.3 years) with public insurance (Medicare or Medicaid), 196 (mean age 71.8 year; P < .001) with combination insurance plans (Medicare plus a privately supplied supplemental), and 12 patients with no insurance (excluded owing to low sample size). There were more current smokers in the public insurance group, more former smokers in the combination insurance group, and more nonsmokers in the private insurance group (P = .03). There were more comorbidities in the public and combination insurance groups versus the private insurance group, including gastroesophageal reflux disease (P = .003), hypertension (P = .01), and hyperlipidemia (P < .001). The groups had no differences in tumor size or pathologic stage. There were higher numbers of intraoperative conversions to open lobectomy in the private and public insurance groups versus the combination insurance group (P = .001). Also, the private and combination insurance groups had more cases of favorable disposition at discharge after surgery compared with the public insurance group (P < .001). Multivariable regression analyses identified private insurance type as an independent predictor of favorable disposition at discharge (public versus private plan; odds ratio, 0.43; 95% confidence interval [CI], 0.22-0.85, P = .02) and 5-year OS (combination versus private plan; hazard ratio, 2.68; 95% CI, 1.26-5.67, P = .01; public versus private plan; HR, 2.84; 95% CI, 1.37-5.89; P = .01). CONCLUSION: Although public or combination insurance type was associated with greater risk of all-cause mortality, and public insurance type was associated with less favorable disposition at discharge after surgery and overall conversion to open lobectomy, insurance type was not associated with increased intraoperative complications, hospital duration of stay, or in-hospital mortality after minimally invasive robotic-assisted pulmonary lobectomy.
引用
- Deol PS, Sipko J, Kumar A, et al. Effect of insurance type on perioperative outcomes after robotic-assisted pulmonary lobectomy for lung cancer. Surgery. 2019. PMID: 31202473. doi:10.1016/j.surg.2019.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。